Загрузка...
Upcoming candidate cerebrospinal fluid biomarkers of Alzheimer’s disease
Dementia due to Alzheimer’s disease (AD) is estimated to reach epidemic proportions by the year 2030. Given the limited accuracy of current AD clinical diagnosis, biomarkers of AD pathologies are currently being sought. Reductions in cerebrospinal fluid levels of β-amyloid 42 (a marker of amyloid pl...
Сохранить в:
| Главные авторы: | , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2012
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3477809/ https://ncbi.nlm.nih.gov/pubmed/22917147 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/bmm.12.42 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|